Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Navigating the GLP-1 Generic Drug Pathway This workshop will address some of the key product development & regulatory assessment considerations for generic GLP-1 agonist products This two-day hybrid (virtual and in-person) workshop focuses on exploring the scientific, regulatory, and technical considerations for developing generic GLP-1 products throughout development
GLP-1 clinical trials didnt measure behaviour change - it's not in the Pharma companies' interests to suggest anything other than the drugs produce weight change, so we don't know how many users were able to achieve or maintain the recommended diet and physical activity
Some people experience breathlessness, dizziness, or heart palpitations due to reduced red blood cell production
Gastrointestinal side effects occurred but rarely reached severity levels requiring treatment discontinuation
GLP-1 (glucagon-like peptide-1) injections are a class of medications that mimic the action of the natural hormone GLP-1, which is involved in metabolic regulation and digestion
Over longer protocols, documentation reveals compliance patterns
US$ 21.74
US$ 26.46
US$ 26.37
US$ 28.01
US$ 25.97
